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INTRODUCTION
The goals of the project were to gain insights into the mechanism by which Notch (in the form of its constitutive form, NICD) transforms rat Schwann cells, and to establish the relationship, if any, between Notch signaling and human MPNSTs.
Notch comprises a family of transmembrane receptors whose interaction with ligand leads to proteolytic cleavages that liberate the Notch intracellular domain, NICD, from the plasma membrane. NICD then enters the nucleus where it activates transcription. Notch's role in several cancers is well established, most notably in T-ALL where a rare chromosomal translocation interrupts the Notch1 gene, resulting in the constitutive expression of NICD. Work has shown that nearly 50% of T-ALLs carry more subtle mutations in the Notch1 gene(1). We have shown that forced expression of NICD can transform rat Schwann cells and that one of our three MPNST cell lines expresses detectable NICD (2) . We therefore proposed that Notch signaling may contribute to the malignant transformation of a subset of neurofibromas in NF1 patients.
BODY

Task 1.
Determine the cause of NICD expression in MPNST cells. a. Determine genomic organization of the Notch genes and expression of Notch ligands in sNF96.2 cells.
We reasoned that the expression of NICD in sNF96.2 cells may be due either to chromosomal rearrangements involving any one of the four the Notch genes (leading to ligand-independent activation) or to over-expression of any one of the five different Notch ligands. Our data have ruled out rearrangements of the Notch1 gene (Southern blots; data not shown) and most likely the other Notch genes as well. Although tentative, the latter conclusion stems from a) the relatively low level of NICD expression in sNF96.2 cells (compared to a T cell line carrying a translocation of the Notch1 gene; data not shown) and b) the dramatic increase in NICD that results when sNF96.2 cells are depleted of calcium (data not shown). Removing calcium activates endogenous Notch genes by shedding their extracellular domains and thus the observation indicates that the endogenous Notch proteins in sNF96.2 cells are not constitutively active. As for ligands, we have determined that Jagged1 is not highly expressed in sNF96.2 cells (data not shown). Expression of the other four ligands has yet to be evaluated.
Conclusions.
We are relatively confident that the NICD expression in sNF96.2 MPNST cells is not due to a grossly rearranged Notch gene. However, work from Jon Aster and Thomas Look has identified subtle Notch mutations that can activate signaling and play a participatory role in hematopoietic malignancies. Such mutations have not yet been looked for in sNF96.2 cells.
We have yet to fully evaluate the potential role of ligand-induced signaling.
Task 2.
Identify the pathways and proteins that collaborate with Notch to induce transformation of rat Schwann cells. a. Examine involvement of Ras-MAPK, PI-3 Kinase, AKT, Jak/Stat and NF-κB. b. Evaluate status of p16Ink4a, E2Fs, and Sox10. c. Determine effect of Notch ligands on transformation-associated phenotypes.
Growth properties of NICD-transduced rat Schwann cells.
One of the questions we addressed concerns why NICD-transduced Schwann cells are transformed. We considered two possibilities: 1) they grow faster and/or 2) they do not undergo contact inhibition. Growth curves comparing parental and NICD-transduced cells (Figure 1 ) showed conclusively that NICD is not mitogenic (indeed, NICD-transduced cells grow somewhat slower), but does allow cells to grow well past confluence, to densities much higher than those observed with parental cells. As with the parental cells, NICD-transduced cells remain forskolin dependent (data not shown), arguing further that NICD does not act as a mitogen. Our experiments have shown that the negative effect of Notch signaling on CyclinD1 is posttranscriptional; that is, Notch does not significantly affect the level of CyclinD1 mRNA (data not shown). The stability of CyclinD1 protein is affected by at least two pathways. One involves GSK3-mediated protein destabilization through phosphorylation of Thr286 (4) . The other involves an APC-related destabilization through a Destruction Box in CyclinD1's N-terminus(5). To better understand the mechanism by which Notch signaling lowers the level of CyclinD1 protein we introduced into NIH 3T3 cells retroviruses that express various Flag-tagged CyclinD1s, either wild type or mutant. The L32A mutant lacks the Destruction Box while the T286A mutant destroys the primary GSK3 phosphorylation site. As shown below (Figure 3 ), only the T286A mutant was refractory to the effect of Notch signaling. Although this result implicates GSK3 in mediating the effect of Notch on CyclinD1 expression, we have not observed a difference in either GSK3 levels or GSK3 phosphorylation (phospho-GSK3 has reduced activity) in cells exposed to Notch ligands (data not shown).
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Wild Type L32A Figure 3 . The CyclinD1 T286A mutant is resistant to the inhibitory effects of Notch signaling. Retroviruses expressing Flag-tagged Wild Type, L32A or T286A CyclinD1 were introduced into NIH 3T3 cells and then the cells were grown on plates coated with Fc (control) or Jagged1 (Jag) for 24 hours. CyclinD1 levels were assessed by Western blot using an anti-Flag antibody and an MRE1 antibody as control.
We next examined the response of CyclinD1 to Notch signaling in our three MPNST cell lines. We reasoned that if Notch signaling is largely responsible for transformation, particularly in the sNF96. Conclusions. If the resistance of CyclinD1 to Notch signaling is a hallmark of Notch-mediated transformation, then we conclude that none of our MPNST cell lines, including sNF96.2, is transformed as a consequence of Notch signaling alone. Furthermore, since NICD-mediated transformation of rat Schwann cells is due to a loss of contact inhibition, future experiments with MPNST cell lines will have to address specifically the role of Notch, if any, in reducing contact inhibition (i.e. their growth in soft agar).
CyclinD1 levels as a function of cell density. Our first experiment was to confirm that CyclinD1 levels were higher in NICD-transformed cells irrespective of cell density. This would rule out artifacts due to the lack of contact inhibition in NICD-transformed cells. As shown in the figure below, CyclinD1 levels were, in fact, higher in NICD-transformed cells irrespective of cell density. Cell cycle analyses. Since Cyclin D1 levels are indeed higher in NICD-transformed cells, then these cells should exhibit an altered cell cycle profile, also independent of cell density. We harvested parental (MigR-transformed) and NICD-transformed cells at different densities (roughly 50% confluent and 100% confluent) and carried out cell cycle analyses using propidium iodide (PI) staining and fluorescence activated cell sorting (FACS). The accompanying table shows that NICD-transformed cells had a higher percentage of cells in S-phase at both low density and high density. This argues that the G1-S transition is faster in NICD-transformed cells, a result expected if CyclinD1 levels are higher.
Although we would generally expect cell populations with a higher percentage of cells in S-phase to be growing faster -in this case they do not -it appears from the above table that cells transformed with NICD are also more delayed in the G2-phase. Thus, these cells may actually not have an overall shorter cell cycle duration and faster rate of division.
Signaling pathways required for growth in soft agar. Our previous data indicated that NICDtransformed cells, but not parental Schwann cells, could grow in soft agar (2) . These results were purely qualitative. We have now repeated these assays, using Ras-transformed NIH 3T3 cells as a control and have included inhibitors of various signaling pathways. It should be pointed out first that we have been able to repeat the soft-agar results (they were performed initially in the lab of our collaborator Dr. Gihan Tennekoon), but that the inherent efficiency is extremely low, being roughly 1 percent that obtained with Ras-transformed NIH 3T3 cells. With regards to the inhibitors, we saw no growth in the presence of Ly, an inhibitor of PI3 Kinase, and very few colonies in the presence of H7, an inhibitor of PKA. Small or no effects were seen in the presence Bis, an inhibitor of PKC, or PD18059, an inhibitor of ERK 1 and 2. We conclude that Notch is either activating or collaborating with the PKA and PI3 Kinase pathways to transform rat Schwann cells.
Effects of Notch ligands and NICD on CyclinD1 transcription.
The CyclinD1 promoter has been proposed to be a direct target of NICD (6) . Although this is not consistent with our data concerning the down-regulation of CyclinD1 by ligand-induced signaling (see 2005 report), we considered the possibility that high concentrations of NICD might be able to transcriptionally activate CyclinD1. Accordingly, we have used quantitative RT-PCR (Q-RT-PCR) to evaluate the effects both of Notch ligands and of NICD on CyclinD1 transcript levels. As shown in the figure below (far right panel), CyclinD1 levels were unchanged when rat Schwann cells were cultured on Fc-Jagged1 and induced slightly (~2.5-fold) in cells transformed with NICD. We conclude 1) that the effect of NICD on the CyclinD1 promoter is dose dependent and 2) that if the CyclinD1 promoter is a direct target of NICD, it is not particularly responsive. Note for comparison the magnitude of NICD-mediated induction of Hes5 or of Hey1. Growth of NICD-transformed cells in soft agar was completely dependent on signaling through PI3 Kinase (see above). PI3 Kinase is known to activate AKT, which is known to inhibit GSK3, which is known to destabilize Cyclin D1. (2) and this correlates with an slight decrease in Hes1 transcript levels (panel 1). Hes3 levels were relatively unchanged (panel 2), while levels of Hes5 transcripts were significantly induced by NICD (panel 3), as expected from higher levels of Hes5 proteins in these cells (2) . Levels of Hey1 transcripts were also increased in the presence of NICD (panel 4). Remarkably, the level of Sox10 transcripts were drastically reduced by NICD (panel 5; not that these data are plotted on a log scale). Given the importance of Sox10 in regulating neural crest development and gliogenesis, this result is very exciting and implicates a role for Notch, directly or indirectly through NICD, in regulating Sox10 transcription. Very little is currently known about the Sox10 promoter. 
Constitutive expression of Hes5 or c-Myc is not sufficient for Schwann cell transformation.
We sought to determine if either Hes5 or c-Myc was sufficient to induce a transformed phenotype in Schwann cells. Accordingly, we obtained retrovirues that constitutively express either Hes5 or c-Myc and used them to transform primary rat Schwann cells. As shown in Figure 9 , constitutive expression of Hes5 did not affect expression of Sox10, Cyclin D1 or c-Myc and so we conclude that Hes5 is unable to mimic the effect of NICD. While constitutive expression of c-Myc was able to enhance the expression of Cyclin D1, it did not down-regulate Sox10 (it actually up regulated Sox10) and it did not result in the loss of contact inhibition (data not shown). We conclude that constitutive expression of c-Myc is also unable to mimic the effects of NICD. Normal Notch signaling requires three proteolytic events that occur in order within the Notch protein to generate NICD, the active form of the receptor. The first occurs independently of ligand while the second is ligand dependent. The third cleavage is constitutive, but depends on the second having occurred beforehand. The third cleavage is carried out by a multiprotein complex referred to as g-Secretase. g-Secretase inhibitors (GSIs) therefore inhibit signaling by preventing the generation of NICD. An artificial form of Notch that mimics the receptor after the first two cleavages is active since it can be acted on by g-Secretase to generate NICD. This form of Notch, which we refer to as NDE, is inactive in the presence of GSI.
Our approach to determine if Notch signaling is reversible employed the use of NDE. We anticipated first transforming Schwann cells with a retrovirus that expresses NDE and then treating the cells with GSI to inactivate NDE. The transformed phenotype would then be assessed over time.
However, to our surprise (and dismay) NDE did not transform Schwann cells. As shown in Figure 10 , while both NICD and NDE induced expression of Hes5 and Hey1, only NICDtransduced cells displayed elevated levels of c-Myc and Cyclin D1. NDE expression did not repress expression of Sox10 (data not shown). To ensure that this was not due simply to low expression from the retrovirus, we flow sorted NDE cells into high expressers (Hi) and low expressers (Lo) based on GFP levels. The high expressers also did not show evidence of transformation (Fig. 10) . Figure 10 forced us to re-examine our original observation that NICD is sufficient to transform Schwann cells. It should be stressed that our early experiences were very consistent and were reproduced many times: each time we transduced Schwann cells with a retrovirus expressing NICD we obtained transformed cells at high frequency. However, this has NOT been the case over the past year. Using exactly the same retrovirus, we do not consistently observe transformed cells. The question is why?
NICD expression is NOT sufficient to transform rat Schwann cells. The results of
It is known that simply growing primary cells in serum can lead to chromosomal rearrangements and transformation, particularly when the cells are "primed" with a known oncogene (10) . Accordingly, we considered two possibilities. First, we explored the idea that the Schwann cells become transformed only after harboring NICD and grown in serum for extended periods of time. Second, we asked if the age of the cells at the time of transduction plays a role, with older cells being more susceptible. Our original experiments were carried out with cells that had been passed 30 times (which is fairly old). Our experiments did not support either of these ideas. As shown in Figure 11 , using cells that had been transduced and immediately frozen three years ago, evidence of transformation (Sox10 down regulation) was apparent as soon as there was sufficient material to evaluate (passage 5). As shown in Figure  12 , cells passed 30 times were not susceptible to transformation by NICD, unless the transformation had been carried out in 2004. New Task:
Determine which class of oncogenes cooperates with NICD to transform Schwann cells.
Dr. Allison Lloyd and colleagues have described a general model for the transformation of rat Schwann cells (11) . Experiments employing activated Ras and various versions of SV40 Large T antigen showed that mitogen-independent growth can be distinguished from mitogen-independent plus anchorageindependent growth. Both are required for Schwann cells to be tumorigenic: the former required both activation of Ras and inactivation of p53, while the latter required, in addition, the inactivation of Rb family members, most likely p107 and/or p130. Interestingly, the ability of T antigen to repress Rb family proteins could be phenocopied by mutations in the cyclin-dependent kinase inhibitor p16
Ink4a . This suggests that p16
Ink4a mutations, while broadly stimulating CDK4 and CDK6, affect primarily the activities of p107 and p130, and not Rb. The reason for this is unknown.
We tested the hypothesis that NICD requires additional events to transform Schwann cells (as determined by anchorage independence) and that these will reflect one or a combination of those events described by Lloyd. Accordingly, we generated Schwann cells that were transduced with NICD plus either a) activated Ras, or b) SV40 Large T antigen. We anticipated that Ras plus T antigen would transform Schwann cells in the absence of NICD(5). According to our hypothesis, we expected NICD to fulfill the role of either activated Ras or T antigen.
An evaluation of cell growth in soft agar (a measure of anchorage independence) confirmed that a combination of Ras plus T antigen led to robust colony formation (below right), while cells containing a) Ras alone (not shown), b) T antigen alone (not shown) or c) parental vectors alone (below left) produced no colonies as expected.
As reported previously, our initial experiments with NICD gave rise to modest colony formation in soft agar (below right) while cells expressing parental vector alone did not produce any growth (below left). Note, however, that the number of colonies was greatly reduced compared to the combination of Ras plus T antigen (8 vs. >400).
Importantly, a combination of NICD plus T antigen also gave robust growth in soft agar (below right, approx. 200 colonies), while NICD plus Ras did not increase the number of colonies over NICD alone (data not shown). We conclude that NICD is fulfilling the role of Ras in promoting anchorage independent growth of Schwann cells.
Is there a molecular signature for anchorage independence?
We had initially speculated that transformation of Schwann cells was accompanied by dedifferentiation; namely, the loss of certain Schwann cell markers such as the transcription factor Sox10 and the myelin protein P0. In this case, the down-regulation of such markers by NICD would not be direct, but be secondary to the transformation process. 
REPORTABLE OUTCOMES
None yet.
CONCLUSIONS
Perhaps the most important conclusion derived from our work is that human MPNST cells lines are not as fully transformed as NICD-transduced rat Schwann cells. Mouse modeling has shown that although Schwann cells are the primary targets of transformation, the microenvironment is also important, as genetic lesions in the Schwann cells alone is not sufficient to generate tumors. Accordingly, absolute proof for a role for Notch signaling in the development of MPNSTs may require mouse modeling.
Our data have refined the relationship between CyclinD1, the cell cycle and the growth rate of NICD-transformed Schwann cells. Solving an apparent paradox, we showed that increased CyclinD1 expression correlates with an increased S-phase population, but that an extended G2 phase may slow the cells growth relative to what we had expected. Our data are also consistent with the increase in CyclinD1 expression being due, in part, to transcriptional effects, possibly mediated by NICD directly.
Our data also show that normal levels of Notch signaling are not sufficient to mediate any of the observed effects of NICD. Thus, while Notch signaling may promote gliogenesis during development, transformation of Schwann cells appears largely unrelated and, in fact, correlates with de-differentiation.
Relationship between Notch and signaling through PI3 Kinase and PKA appear to be important for transformation, but such a relationship between Notch and Stat transcription factors, despite supporting evidence in neurons, does not appear to exist in glial cells.
While our data describing NICD-transformed Schwann cells remain valid, we can no longer conclude that NICD is sufficient for oncogenic transformation. We have now begun to unravel the mechanism through which NICD transforms Schwann cells and also down-regulates Sox10 and ErbB3. NICD appears to act similarly to Ras in promoting anchorage-independent growth. Transformation and Sox10/ErbB3 down-regulation are not necessarily linked.
Our initial hypothesis was that aberrant Notch signaling contributes to the development of MPNSTs. Our results argue against this hypothesis (note paragraph above) and suggest that Notch's role in Schwann cell transformation may be complex, requiring the collaboration of additional oncogenes. We still do not understand why our first experiments (those that served as the basis of this grant) so clearly demonstrated that NICD was sufficient for the transformation process.
